Tokyo Tape
Sign in
← Yamashita Health Care Holdings

Quarterly report · Q3

9265.TEDINET S100T8KZ
Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥45.4bn2023-06-01 → 2024-02-29Cons.Net sales
Revenue¥58.2bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥41.7bn2022-06-01 → 2023-02-28Cons.Net sales
Operating income¥830m2023-06-01 → 2024-02-29Cons.Operating income
Operating income¥895m2022-06-01 → 2023-02-28Cons.Operating income
Ordinary income¥871m2023-06-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.2bn2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥936m2022-06-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥721m2023-06-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥333m2022-06-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥442m2023-06-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥219m2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥438m2023-06-01 → 2024-02-29Cons.Profit loss
Net income−¥3m2022-06-01 → 2023-02-28Cons.Profit loss
Total assets¥25.6bnat 2024-02-29Cons.Assets
Total assets¥24.6bnat 2023-05-31Cons.Assets
Total assets¥22.5bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥17.2bnat 2024-02-29Cons.Liabilities
Total liabilities¥16.6bnat 2023-05-31Cons.Liabilities
Net assets / equity¥8.4bnat 2024-02-29Cons.Net assets
Net assets / equity¥7.9bnat 2023-05-31Cons.Net assets
Net assets / equity¥7.7bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥4.5bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥5.8bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥173.232023-06-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-14.832023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥85.832022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.462022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥79.442022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio32.8%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio32.2%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.2%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-06-01 → 2024-02-29¥0
Reconciling Itemsreconcilingrevenue intersegment2023-06-01 → 2024-02-29¥0
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2024-02-29−¥844m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2023-06-01 → 2024-02-29¥209m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2023-06-01 → 2024-02-29¥209m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥0
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2023-06-01 → 2024-02-29¥2m
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue2023-06-01 → 2024-02-29¥45.1bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue external2023-06-01 → 2024-02-29¥45.1bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥0
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentsegment profit2023-06-01 → 2024-02-29¥1.7bn
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue2023-06-01 → 2024-02-29¥51m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue external2023-06-01 → 2024-02-29¥51m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentsegment profit2023-06-01 → 2024-02-29¥1m
—segment totalrevenue2023-06-01 → 2024-02-29¥45.4bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥45.4bn
—segment totalrevenue intersegment2023-06-01 → 2024-02-29¥0
—segment totalsegment profit2023-06-01 → 2024-02-29¥1.7bn
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-02-28−¥11m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-02-28−¥11m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥690m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2022-06-01 → 2023-02-28¥211m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2022-06-01 → 2023-02-28¥211m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥0
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2022-06-01 → 2023-02-28¥10m
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue2022-06-01 → 2023-02-28¥41.5bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue external2022-06-01 → 2023-02-28¥41.5bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥11m
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentsegment profit2022-06-01 → 2023-02-28¥1.6bn
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue2022-06-01 → 2023-02-28¥50m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue external2022-06-01 → 2023-02-28¥50m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentsegment profit2022-06-01 → 2023-02-28¥0
—segment totalrevenue2022-06-01 → 2023-02-28¥41.7bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥41.7bn
—segment totalrevenue intersegment2022-06-01 → 2023-02-28¥11m
—segment totalsegment profit2022-06-01 → 2023-02-28¥1.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 366
ItemContextValueUnit
Net salesPrior1YTDDuration41725000000JPY
Net salesCurrentYTDDuration45373000000JPY
Cost of salesPrior1YTDDuration36017000000JPY
Cost of salesCurrentYTDDuration39281000000JPY
Gross profitPrior1YTDDuration5708000000JPY
Gross profitCurrentYTDDuration6092000000JPY
Selling general and administrative expensesPrior1YTDDuration4813000000JPY
Selling general and administrative expensesCurrentYTDDuration5261000000JPY
Operating incomePrior1YTDDuration895000000JPY
Operating incomeCurrentYTDDuration830000000JPY
Interest and dividends income noiPrior1YTDDuration8000000JPY
Interest and dividends income noiCurrentYTDDuration9000000JPY
Purchase discounts noiPrior1YTDDuration10000000JPY
Purchase discounts noiCurrentYTDDuration11000000JPY
Commission fee noiPrior1YTDDuration20000000JPY
Commission fee noiCurrentYTDDuration19000000JPY
Other noiPrior1YTDDuration14000000JPY
Other noiCurrentYTDDuration20000000JPY
Non operating incomePrior1YTDDuration55000000JPY
Non operating incomeCurrentYTDDuration61000000JPY
Interest expenses noePrior1YTDDuration1000000JPY
Interest expenses noeCurrentYTDDuration0JPY
Foreign exchange losses noePrior1YTDDuration1000000JPY
Foreign exchange losses noeCurrentYTDDuration4000000JPY
Loss on sales of notes payable noePrior1YTDDuration5000000JPY
Loss on sales of notes payable noeCurrentYTDDuration5000000JPY
Compensation expenses noePrior1YTDDuration－JPY
Compensation expenses noeCurrentYTDDuration3000000JPY
Equity in losses of affiliates noePrior1YTDDuration3000000JPY
Equity in losses of affiliates noeCurrentYTDDuration4000000JPY
Other noePrior1YTDDuration0JPY
Other noeCurrentYTDDuration1000000JPY
Non operating expensesPrior1YTDDuration14000000JPY
Non operating expensesCurrentYTDDuration20000000JPY
Ordinary incomePrior1YTDDuration936000000JPY
Ordinary incomeCurrentYTDDuration871000000JPY
Reversal of allowance for doubtful accounts eiPrior1YTDDuration－JPY
Reversal of allowance for doubtful accounts eiCurrentYTDDuration54000000JPY
Receipts from contingent consideration eiPrior1YTDDuration6000000JPY
Receipts from contingent consideration eiCurrentYTDDuration－JPY
Gain on sales of investment securities eiPrior1YTDDuration1000000JPY
Gain on sales of investment securities eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration8000000JPY
Extraordinary incomeCurrentYTDDuration54000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration－JPY
Loss on sales of noncurrent assets elCurrentYTDDuration4000000JPY
Impairment loss elPrior1YTDDuration－JPY
Impairment loss elCurrentYTDDuration200000000JPY
Provision of allowance for doubtful accounts elPrior1YTDDuration611000000JPY
Provision of allowance for doubtful accounts elCurrentYTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass
balance sheet identityconsolidated 2024-02-29pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass